Annual Production Capacity

• 
• CDMO
• Manufacturing process
• Injection plant
• Annual Production Capacity

As we relentlessly strive towards innovative quality with various pharmaceutical development pipelines, we are making a quantum leap to become the best CMO acknowledged in overseas markets such as the US and the EU, let alone Korea.

• 
• 

The general injection production line has the capacity to provide CMO production services on a variety of general injections including powders, liquids, lyophilizated vial injections and liquids, lyophilizated ampoule injections, and PFS (Pre-Filled Syringe).

Line classification			Unit	Current annual production CAPA
				Batch	Vial/Amp/Syringe
Vial	Lyophilization & Liquid	Lyophilization Machine No. 1 (Kyohwa No. 1)	22-Ø vial	80	2,400,000
		Lyophilization Machine No. 2 (Kyohwa No. 2)		80	4,800,000
		Lyophilization Machine No. 3 & 4 (Lili No. 1 & 2)		100	12,000,000
	Powder		22-Ø vial	200	10,000,000
Ampoule (Lyophilization, Liquid)			11.2Ø(1mL) Ampoule	200	12,000,000
Pre-filled Syringe			5mL Syringe (High viscosity)	100	10,000,000 (6,000,000)